socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. and $16.00

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

NOVEMBER 14, 2013

San Diego-based medical device manufacturer Tandem Diabetes Care priced its IPO last night, saying it will offer up 8,000,000 shares of its common stock at $15.00 The company--which develops an insulin pump--will start trading today on the NASDAQ Global Market as TNDM. READ MORE>>.

Pricing 153

Pricing San Diego Startup Acquisition 153

socalTECH

JUNE 28, 2012

San Diego-based ServiceNow priced its IPO on Thursday, at $18.00 The firm's IPO performance is being closely watched, as it is the first, technology IPO to hit the markets since the Facebook IPO debacle. per share, above its estimated initial offering range of $15.00 READ MORE>>.

Pricing 150

Pricing Marketing San Diego Equity 150

socalTECH

MAY 16, 2013

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 The company will start trading today on the NASDAQ Global Market as AMBI. Ambit priced well below its estimated initial public offering range, which had been set at between $13.00

Pricing 138

Pricing San Diego Startup Acquisition 138

socalTECH

APRIL 25, 2013

San Diego-based biopharmaceuticals developer Receptos has set the initial, estimated pricing range for its IPO, saying in a filing Thursday that it now expects its IPO pricing to be between $14.00 receptos merger acquisition lifescience biopharma biopharmaceuticals rcpt exit' and $16.00 READ MORE>>.

Pricing 153

Pricing San Diego Acquisition Funding 153

socalTECH

AUGUST 16, 2021

San Diego-based sales and marketing software developer Seismic has raised $170M in a Series G funding round, the company said this morning, and is now valued at $3 billion. Rowe Price, according to the company. Financial details of that acquisition were not announced. Seismic has now raised $440M in total funding.

San Diego 113

San Diego Coach Sales Training 113

socalTECH

JULY 25, 2012

San Diego-based Peregrine Semiconductor , the developer of CMOS, RF integrated circuits, has set an estimated pricing range for its its IPO. According to a filing by the firm this morning, it is estimating a IPO price of between $14.00 The firm also said it has applied to list on the Nasdaq Global Market as PSMI.

Pricing 145

Pricing San Diego Equity Marketing 145

socalTECH

AUGUST 8, 2012

San Diego-based Peregrine Semiconductor priced its IPO last night, saying that it will offer up 5,500,000 shares of its common stock at $14.00 The firm will start trading today on the NASDAQ Global Market as PSMI. Peregrine priced at the low end of its initial estimated pricing range, which was $14.00

Pricing 133

Pricing San Diego Startup Equity 133

socalTECH

AUGUST 2, 2010

San Diego-based Trius Therapautics has slashed its IPO offering price, saying today in a filing with the SEC that it will offer 10,000,000 shares of its common stock at $5.00 The firm, which will list on the Nasdaq Global Market as TSRX, had initially said it would sell 6,000,000 shares of its stock at between $12.00

Pricing 150

Pricing San Diego Acquisition Marketing 150

socalTECH

MAY 25, 2011

San Diego-based The Active Network , the operator of sports and community event registration services and websites, priced its IPO Wednesday evening, saying it will sell 11,000,000 shares of its common stock at $15.00 Active priced below its expected initial offering range, which was $16.00 READ MORE>>.

Activity 124

Activity Pricing Networking San Diego 124

socalTECH

SEPTEMBER 25, 2013

San Diego-based Evoke Pharma , a biopharmaceuticals firm focused on gastrointestinal disease, raised $25M in an IPO this morning, but is trading down from its IPO debut. The company, which is now trading as EVOK on the Nasdaq Global Market, debuted at $12 per share this morning, and was recently trading around $11.13.

Pricing 147

Pricing San Diego Acquisition Marketing 147

socalTECH

NOVEMBER 4, 2010

San Diego-based Zogenix has updated its S-1, saying this morning the firm intends to offer 6 million shares of its common stock on the Nasdaq Global Market as ZGNX. The firm also said it currently estimates the firm's initial offering price at between $12.00 and $14.00 Zogenix had filed for an IPO in September.

Pricing 140

Pricing San Diego Acquisition Marketing 140

socalTECH

MARCH 15, 2021

San Diego-based Longboard Pharmaceuticals, which is developing medicines for neurological diseases, raised $80M in its IPO last week, selling 5,000,000 shares of its common stock at a price of $16.00 The company is now trading on the Nasdaq Global Market as LBPH.

San Diego 113

San Diego Pricing Design Marketing 113

socalTECH

AUGUST 3, 2010

San Diego-based Trius Therapeutics is set to hit the markets today, after pricing its IPO last night. Trius will trade on the NASDAQ Global Market under the symbol TSRX. The IPO is being underwritten by Citigroup Global Markets, Piper Jaffray & Co., Canaccord Genuity Inc. and JMP Securities. READ MORE>>.

Marketing 140

Marketing San Diego Pricing Acquisition 140

socalTECH

NOVEMBER 10, 2010

One of the portfolio firms of San Diego-based venture capital firm Enterprise Partners , Complete Genomics is set to debut on the market Thursday, after pricing its IPO this evening. Complete Genomics will trade on the NASDAQ Global Market as GNOM. per share, below an earlier estimated range of $12.00

Enterprise Partners 124

Enterprise Partners Marketing San Diego Acquisition 124

socalTECH

JULY 16, 2010

RealD said last night that it had priced its IPO at $16.00, and is selling 12.5M Tags: financing public market acquisition merger reald. shares of its common stock. RealD joins Woodland Hills-based ReachLocal and Carlsbad-based MaxLinear among the list of local firms with a successful IPO this year.

Westlake Village 145

Westlake Village Woodland Hills Thousand Oaks ReachLocal 145

socalTECH

APRIL 8, 2019

San Diego-based Guardion Health Sciencs , which is developing "condition-specific medical foods and testing technologies" for the ocular health market, has raised $5.0M The company priced its IPO on Friday, selling 1,250,000 shares of its common stock at a price of $4.00 in a small IPO. READ MORE>>.

San Diego 113

San Diego Pricing Capital Marketing 113

socalTECH

MAY 28, 2019

San Diego-based Cibus , a developer of gene editing tools being aimed at use in plant breeding, has pulled its IPO paperwork, saying in a filing that it has decided "not to proceed with the initial public offering of its securities at this time." Cibus had set an estimated initial pricing range of $14.00 READ MORE>>.

San Diego 113

San Diego Pricing Tool Invest 113

socalTECH

MAY 9, 2013

San Diego-based biopharmaceuticals developer Receptos is trading flat after its initial public offering, after pricing last night at $14.00 The developer of biopharmaceuticals for treating immune and metabolic diseases priced at the low end of its estimated IPO range, which was $14.00 READ MORE>>.

San Diego 159

San Diego Pricing Venture Capital Acquisition 159

Xconomy

JULY 31, 2020

The biotech IPO market is buzzing but Cerevel Therapeutics is showing that there’s more than one path to the public markets. This week the neuroscience drug developer reached a deal to merge with publicly traded Arya Sciences Acquisition Corp II.

Pricing 72

Pricing Acquisition Capital Marketing 72

socalTECH

SEPTEMBER 3, 2014

San Diego-based biopharmaceuticals developer Viking Therapeutics has set the estimated pricing for its IPO, saying in a filing Tuesday that it expects to price its IPO at between $10.00 The company has applied to list as VKTX on the NASDAQ Global market. and $12.00 The company is hoping to raise up to $69.0M

San Diego 138

San Diego Pricing Research Acquisition 138

socalTECH

AUGUST 13, 2014

San Diego-based biopharmaceuticals firm Otonomy was up today in early trading, after pricing 6.25 today after its debut on the NASDAQ Global Market as OTIC. The company priced at the high end of its initial estimated IPO range, which was $14.00 otonomy merger acquisition biotech lifescience otic nasdaq exit'

Avalon 138

Avalon San Diego Pricing Acquisition 138

socalTECH

OCTOBER 1, 2013

San Diego-bsaed Fate Therapeutics , which is developing biopharmaceuticals base don adult stem cells to treat a number of orphan diseases, is up slightly in trading after its initial public offering this morning. Fate Therapeutics priced at $6.00 The company is now trading as FATE on the NASDAQ Global Market. and $16.00

San Diego 157

San Diego Pricing Acquisition Marketing 157

socalTECH

SEPTEMBER 17, 2018

San Diego-based Senomyx , a developer of artificial flavoring ingredients and sweeteners for the beverage and food market, has been acquired by Switzerland's Firmenich , in a deal worth approximately $72.5M. The deal is an approximately 43 percent premium over the closing price of Senomyx on September 14th.

San Diego 113

San Diego Pricing Marketing Develop 113

socalTECH

SEPTEMBER 23, 2019

A portfolio company of San Diego-based biopharmaceuticals venture investor Versant Ventures is getting set for its IPO this week. Aprea Therapeutics said that estimates its IPO will price between $14.00 Aprea--based in Boston and Sweden--says it has applied to list on the Nasdaq Global Select Market under the symbol APRE.

San Diego 113

San Diego Pricing Invest Marketing 113

socalTECH

APRIL 14, 2017

San Diego-based gene therapy developer Tocagen rose in its IPO this morning, after pricing at $10.00 per share, after its debut on the NASDAQ Global Select Market as TOCA. The company priced its IPO at the low end of an initial estimated $10.00 The company now has a market cap of approximately $187M.

San Diego 127

San Diego Pricing Marketing Product 127

socalTECH

JANUARY 20, 2015

San Diego-based biopharmaceuticals developer Tracon Pharmaceuticals said in a regulatory filing today that it is estimated its IPO pricing at between $12.00 The company--which filed for an IPO over the holidays--is looking to raised $57.96M on the NASDAQ Global Market as TCON. and $14.00 READ MORE>>.

San Diego 100

San Diego Acquisition Pricing Invest 100

socalTECH

NOVEMBER 27, 2017

San Diego-based Odonate Therapeutics , a startup that says it is hoping to develop chemotherapy drugs, is looking to raised $182.5M in an IPO on the NASDAQ Global Select Market. The company has set its estimated IPO price range at between $24.00 and $27.00

San Diego 113

San Diego Pricing Capital Funding 113

socalTECH

JUNE 29, 2012

San Diego-based ServiceNow has proven that the market for initial public offerings is still strong this morning, opening up at $23.08 The firm priced its IPO above estimates, at $18.00 The firm had earlier estimated an initial pricing range of $15.00 JMI Equity is based in San Diego. READ MORE>>.

San Diego 176

San Diego Equity Pricing Invest 176

socalTECH

JANUARY 26, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M Anaptys priced its IPO on Wednesday night at $15.00 The company now trades as ANAB on the NASDAQ Global Select Market. in its IPO, and closed up slightly in its first day of trading on Thursday. READ MORE>>.

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

JULY 22, 2010

Southern California appears to be on a IPO roll this month, with the pricing of Monrovia-based Green Dot 's IPO last night and expected trading today, following the successful IPO of Beverly Hills-based RealD last Friday. Tags: southern california merger acquisition gdot reald.

Southern California 140

Southern California Westlake Village Woodland Hills Beverly Hills 140

socalTECH

MAY 7, 2015

San Diego-based biotech developer aTyr Pharma is debuting in its IPO this morning, after pricing its IPO at $14.00 the company will trade as LIFE on the NASDAQ Global Market starting this morning. per share last night. The company raised $75M in the offering.

San Diego 100

San Diego Pricing Invest Marketing 100

socalTECH

MAY 20, 2010

per share, after pricing below its initial offering range on Wednesday evening, and had traded as high as $15.26 The firm's stock was up in its debut despite a down market for the day, with the NASDAQ down -4.11 Tags: reachlocal advertising small business exit merger acquisition. during the day. percent to 2,204.01. READ MORE>>.

ReachLocal 157

ReachLocal Woodland Hills Thousand Oaks NewEgg 157

Xconomy

FEBRUARY 4, 2019

Battery-technology business Maxwell Technologies has agreed to be acquired by Silicon Valley electric car company Tesla (NASDAQ: TSLA ) in an all-stock deal valued at about $218 million, the San Diego-based company announced Monday. apiece, a 55 percent premium over its stock price as of market close Feb.

Technology 46

Technology San Diego Pricing News 46

socalTECH

AUGUST 6, 2012

San Diego-based RFIC maker Peregrine Semiconductor is looking to be the next, Southern California technology company to make it to the public markets, with an IPO on Wednesday, according to the NASDAQ's IPO calendar. Peregrine is looking to raised $83M in an IPO, which is currently estimated to price at between $14.00

Southern California 145

Southern California San Diego Equity Pricing 145

socalTECH

JANUARY 14, 2011

The filing of an IPO by Los Angeles-based Boingo Wireless on Friday seems to indicate the interest in public markets by venture-backed, Southern California firms has not abated. The filing comes on the heels of Demand Media 's kickoff of its roadshow to Wall Street on Wednesday, after it set an initial pricing range on its own IPO offering.

Southern California 162

Southern California Santa Monica Legalzoom ReachLocal 162

socalTECH

JUNE 19, 2012

Reports this morning say that San Diego-based ServiceNow is planning to start its IPO roadshow this week, as the firm looks to brave a post-Facebook-IPO market. According to reports , the firm expects to price its IPO as late June.

Report 145

Report Southern California San Diego Equity 145